Abisola Idu, MS, MPH
“I apply well-established and innovative statistical methods to clinical and public health research. My objective is to support, challenge, or capture new findings that influence decisions that can improve health and health care, worldwide."
Abisola Idu, MS, MPH
Collaborative Biostatistician I, Kaiser Permanente Washington Health Research Institute
Abisola.Idu@kp.org
206-287-2893
Biography
Biostatistician Abisola Idu, MS, MPH, is interested in research that investigates the effectiveness and efficacy of treatment in pharmacoepidemiologic studies. She has a broad range of interest in research with a strong motivation to investigate the health challenges of malaria, obesity, cancer, heart disease, and maternal health.
Ms. Idu began her contributions to clinical and public health research through her academic training at the University of Texas Health Science Center, School of Public Health. She further got rigorous research experience by being a part of the leukemia, lymphoma, and cancer prevention research team at The University of Texas M.D. Anderson Cancer Center in 2015. She has been a biostatistician at Kaiser Permanente Washington Health Research Institute's Biostatistics Unit since 2018.
Ms. Idu looks forward to using her expertise in application of epidemiological principles and surveillance methodologies at KPWHRI. She has an in-depth knowledge of the ICH-GCP, FDA, IRB policies, regulations, and guidelines and plans to use her skills and background to implement epidemiologic study designs in clinical research studies.
Research interests and experience
-
Cancer
Efficacy and safety of therapies; association between genetic variability and survival outcomes
-
Obesity
Role of nutritional, psychological and lifestyle factors; obesity prevention and control
-
Heart Disease
Role of aging, nutritional and lifestyle factors; Intervention strategies for prevention and disease control
-
Maternal Health
Association between social, behavioral and clinical factors and maternal and infant outcomes
-
Malaria
Malaria prevention and control; development of vaccines; availability and accessibility to malaria treatment
-
Women's Health
-
Mental Health
-
Biostatistics
-
Social Determinants of Health
-
Vaccines & Infectious Diseases
-
Cardiovascular Health
Recent publications
Rosenberg DE, Wu Y, Idu A, Greenwood-Hickman MA, McCurry SM, LaCroix AZ, Shaw PA. Historic cognitive function trajectories as predictors of sedentary behavior and physical activity in older adults. J Gerontol A Bio Sci Med Sci. 2024; May 15:glae125. doi: 10.1093/gerona/glae125. PubMed
Dublin S, Greenwood-Hickman MA, Karliner L, Hsu C, Coley RY, Colemon L, Carrasco A, King D, Grace A, Lee SJ, Walsh JME, Barrett T, Broussard J, Singh U, Idu A, Yaffe K, Boustani M, Barnes DE. The electronic health record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Brain Health Trial: Protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithm. Contemp Clin Trials. 2023;135:107356. doi: 10.1016/j.cct.2023.107356. Epub 2023 Oct 17. PubMed
Wartko PD, Bobb JF, Boudreau DM, Matthews AG, McCormack J, Lee AK, Qiu H, Yu O, Hyun N, Idu AE, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Labelle CT, Zare-Mehrjerdi M, Stotts AL, Braciszewski JM, Murphy MT, Dryden D, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Phillips RC, Shea M, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Lapham GT, Addis M, Bradley KA; PROUD Trial Collaborators; Ghiroli MM, Hamilton LK, Hu Y, LaHue JS, Loree AM, Murphy SM, Northrup TF, Shmueli-Blumberg D, Silva AJ, Weinstein ZM, Wong MT, Burganowski RP. Nurse care management for opioid use disorder treatment: The PROUD cluster randomized clinical trial. JAMA Intern Med. 2023 Oct 30:e235701. doi: 10.1001/jamainternmed.2023.5701. [Epub ahead of print]. PubMed
Glass JE, Dorsey CN, Beatty T, Bobb JF, Wong ES, Palazzo L, King D, Mogk J, Stefanik-Guizlo K, Idu A, Key D, Fortney JC, Thomas R, McWethy AG, Caldeiro RM, Bradley KA. Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial). Implement Sci. 2023 Feb 1;18(1):3. doi: 10.1186/s13012-022-01258-9. PubMed
Wartko PD, Qiu H, Idu AE, Yu O, McCormack J, Matthews AG, Bobb JF, Saxon AJ, Campbell CI, Liu D, Braciszewski JM, Murphy SM, Burganowski RP, Murphy MT, Horigian VE, Hamilton LK, Lee AK, Boudreau DM, Bradley KA. Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systems. BMC Health Serv Res. 2022 Dec 29;22(1):1593. doi: 10.1186/s12913-022-08915-1. PubMed
Cheetham TC, Shortreed SM, Avalos LA, Reynolds K, Holt VL, Easterling TR, Portugal C, Zhou H, Neugebauer RS, Bider Z, Idu A, Dublin S. Identifying hypertensive disorders of pregnancy, a comparison of two epidemiologic definitions. Front Cardiovasc Med. 2022 Nov 23;9:1006104. doi: 10.3389/fcvm.2022.1006104. eCollection 2022. PubMed
Research
Increasing opioid use disorder treatment in primary care
A trial led by KPWHRI researchers found that adding nurse care managers helped more people get needed treatment.
Research
Dementia risk screening tool shows promise
In a new study, a tool to help discover undiagnosed dementia performed well in 2 separate health systems.
Research
New findings on treating hypertension in pregnancy
A study led by Dr. Sascha Dublin finds similar outcomes for 3 hypertension medications, filling an evidence gap.
COVID-19
Greater infection risks linked to COVID-19 disparities
New work by Susan Shortreed, PhD, finds infection risks drive worse outcomes for some racial and ethnic groups.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.